Wallace Capital Management’s Amgen AMGN Stock Holding History

Wallace Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$253K	Sell	719 -25	-3%	-$8.91K	0.03%	63
2025 Q4	$244K	Buy	+744	New	+$236K	0.03%	69
2025 Q2	–	Sell	-644	Closed	-$201K	–	73
2025 Q1	$201K	Buy	+644	New	+$190K	0.03%	78
2024 Q4	–	Sell	-644	Closed	-$208K	–	82
2024 Q3	$208K	Hold	644	–	–	0.03%	76
2024 Q2	$201K	Buy	+644	New	+$189K	0.03%	74
2020 Q1	–	Sell	-844	Closed	-$203K	–	62
2019 Q4	$203K	Buy	+844	New	+$186K	0.03%	61

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wallace Capital Management's AMGN Position: Q1 2026 in Review

Wallace Capital Management reduced its Amgen (AMGN) stake by 3.4% in Q1 2026, selling an estimated $8.91K and leaving 719 shares worth $253K. The position accounts for 0.03% of the portfolio, ranked #63.

Wallace Capital Management first reported a position in AMGN in Q4 2019 and has held it in 6 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Wallace Capital Management held 719 shares of Amgen worth $253K as of Q1 2026.
Wallace Capital Management sold 25 Amgen shares in Q1 2026, an estimated $8.91K.
Amgen made up 0.03% of Wallace Capital Management's portfolio in Q1 2026, its #63 holding.
Wallace Capital Management first reported a position in Amgen in Q4 2019 and has held it in 6 quarters since.
3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Wallace Capital Management's 13F filing for Q1 2026, filed 15 May 2026.